In a strongly-worded opinion column for The Indian Express on the Ranbaxy fraud published last week, Amir Attaran of the University of Ottawa rightly calls on the Indian government to do more to ensure that drugs produced in India are safe and effective. But Attaran is wrong is when he uses references to the fraud … Continue reading Guest column : The Ranbaxy fraud has revived the “counterfeits” debate. It shouldn’t.
Apothecurry 